SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Heidenreich A, Varga Z, von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy in prostate cancer: high incidence of lymph node metastases. J Urol 2002; 167: 16816
  • 2
    Schuhmacher MC, Burkhard FC, Thalmann GN, Fleischmann A, Studer UE. Is pelvic lymph node dissection necessary in patients with a serum PSA 10 ng/mL undergoing radical prostatectomy for prostate cancer? Eur Urol 2006; 50: 2729
  • 3
    Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≤10 ng/mL and biopsy Gleason score ≤6, and their influence on PSA progression-free survival after radical prostatectomy. BJU Int 2006; 97: 11738
  • 4
    DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML. The extent of pelvic lymphadenectomy for pTxPn0 prostate cancer does not influence prostate cancer outcomes in the prostate specific antigen era. J Urol 2005; 173: 11215
  • 5
    Heidenreich A, Aus G, Bolla M et al. EAU guidelines on prostate cancer. Eur Urol 2008; 53: 6880
  • 6
    Harisinghani MG, Barentsz J, Hahn PF et al. Noninvasive detection of clinically occult lymph node metastases in prostate cancer. N Engl J Med 2003; 348: 24919
  • 7
    De Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Meninsk HJ. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. J Nucl Med 2003; 44: 3315
  • 8
    Heidenreich A, Ohlmann CH, Polyakov S. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. Eur Urol 2007; 52: 2937
  • 9
    Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004; 172: 18404
  • 10
    Joslyn SA, Konety BR. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 2006; 68: 1215
  • 11
    Berglund RK, Sadetsky N, DuChane J, Carroll PR, Klein EA. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. J Urol 2007; 177: 5269
  • 12
    Weight CJ, Reuther AM, Gunn PW, Zippe CR, Dhar NB, Klein EA. Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer. Urology 2008; 71: 1415
  • 13
    Masterson TA, Bianco FJ Jr, Vickers AJ et al. The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. J Urol 2006; 175: 13204
  • 14
    D’Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 96974
  • 15
    Conrad S, Graefen M, Pichlmeier U, Henke RP, Hammerer PG, Huland H. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol 1998; 159: 20239
  • 16
    Haese A, Epstein JI, Huland H, Partin AW. Validation of a biopsy based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostatic carcinoma. Cancer 2002; 95: 101621
  • 17
    Graefen M, Ohori M, Karakiewicz PI et al. Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer. J Urol 2004; 171: 2004
  • 18
    Freedland SJ, Aronson WJ, Csathy GS et al. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database. Urology 2003; 61: 7427
  • 19
    Quinn DI, Henshall SM, Brenner PC et al. Prognostic significance of preoperative factors in localized prostatic carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer 2003; 97: 188493
  • 20
    Briganti A, Karakiewicz PI, Chun FKH et al. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymphadenectomy. Eur Urol 2007; 51: 157381
  • 21
    Graefen M, Walz J, Huland H. Open retropubic nerve-sparing radical prostatectomy. Eur Urol 2006; 49: 3848
  • 22
    Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002; 168: 5148
  • 23
    Kawakami J, Meng MV, Sadetsky N et al. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol 2006; 176: 13826
  • 24
    Briganti A, Blute ML, Eastham JH et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009; 55: 125165
  • 25
    Clark T, Parkeh DJ, Cookson MS et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003; 169: 1458
  • 26
    Briganti A, Chun FK, Salonia A et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006; 50: 100613